Clinical Trials Logo

Filter by:
NCT ID: NCT03991143 Completed - Clinical trials for ST Elevation Myocardial Infarction

Efficacy, Safety and Tolerability of ATH3G10 in Patients With ST-elevation Myocardial Infarction

Start date: March 29, 2019
Phase: Phase 2
Study type: Interventional

Patients with ST-segment elevation myocardial infarction (STEMI) that have suffered a major anterior wall infarction or where coronary blood flow is less than normal in spite of successful percutaneous coronary intervention (PCI) have a poor prognosis. There are today no medical treatments that specifically reduce risk in these patients. The acute inflammatory reaction in conjunction with a STEMI and reperfusion by PCI determines the final size of the infarction and the signals leading to left ventricular remodelling. This study is designed to assess the efficacy and safety of single intravenous injection with ATH3G10, a fully human IgG1 antibody against phosphorylcholine, in high-risk subjects with STEMI. ATH3G10 aims to reduce inflammation and thereby infarction size and remodeling.

NCT ID: NCT03990688 Completed - Healthy Clinical Trials

A Study to Assess the Effect of AK3280 on Renal Function in Healthy Subjects

Start date: October 3, 2019
Phase: Phase 1
Study type: Interventional

AK3280 is being developed to further improve the long-term efficacy and tolerability of treatment options for patients with fibrotic disorders.This study will evaluate the effect of AK3280 treatment on renal function and safety, and the PK of AK3280 compared with placebo in healthy subjects.

NCT ID: NCT03990506 Completed - Keratoconus Clinical Trials

Photorefractive Intrastromal Crosslinking (PiXL) for the Treatment of Progressive Keratoconus

Start date: April 2, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy, safety and postoperative ocular discomfort by comparing individually customized Photorefractive intrastromal crosslinking (PiXL) for progressive Keratoconus. The study compares two different protocols, PiXL with corneal epithelium debridement (Epi-off) and PiXL without epithelium debridement in high oxygen environment (Epi-on), with the hypothesis that Epi-on gives less postoperative ocular discomfort.

NCT ID: NCT03989518 Completed - Healthy Subjects Clinical Trials

The Link Between Mental Imagery and the Reduction of Fear in Imaginal Extinction

Start date: February 25, 2019
Phase: N/A
Study type: Interventional

Imaginal exposure is a widely used psychological treatment technique. Imaginal extinction is an experimental analogue of imaginal exposure, that allows the study of this treatment technique under controlled circumstances (Agren, Björkstrand, & Fredrikson, 2017). During imaginal extinction, experimentally induced fear is diminished through repeated exposure to mental imagery of the feared (conditioned) stimulus. However, it is not known to what extent fear reduction depends on the mental imagery produced during this procedure. A better understanding of the mechanisms driving the effects of imaginal exposure and the factors moderating fear reduction could have significant clinical utility, by suggesting mechanistically informed ways to improve this treatment.

NCT ID: NCT03989167 Recruiting - Clinical trials for Hypercholesterolemia, Familial

Clinical Decision Support for Familial Hypercholesterolemia

CDS-FH
Start date: December 6, 2022
Phase: N/A
Study type: Interventional

A cluster randomized study in the primary care setting to evaluate a computer-based clinical decision support system to aid in the identification and management of patients with FH. The primary outcome of the study is the number of patients diagnosed with FH at thirty months after study initiation.

NCT ID: NCT03987880 Completed - Myopia Clinical Trials

Photorefractive Intrastromal Corneal Crosslinking as a Treatment for Low Grade Myopia

Start date: January 22, 2018
Phase: N/A
Study type: Interventional

To assess the improvement in refractive error and the corneal endothelial safety with a customized corneal crosslinking treatment regimen for low grade myopia. The study compares two treatment protocols, a 4.0-mm central ring-shaped zone with a 3.5-mm central ring-shaped zone in high oxygen environment without corneal epithelial debridement.

NCT ID: NCT03986476 Completed - IBS Clinical Trials

The Effect of Two Probiotic Products on the Intestinal Barrier Function in Patients With Irritable Bowel Syndrome

Start date: March 26, 2019
Phase: N/A
Study type: Interventional

This study will investigate the effects of supplementation with two different probiotic products (Lactobacillus reuteri strains) on the intestinal barrier function, gut health and stress symptoms in diarrhoea-predominant irritable bowel syndrome (IBS-D) patients.

NCT ID: NCT03985514 Completed - Appendicitis Clinical Trials

Acute Appendicitis: Active Observation With and Without Antibiotics

Start date: May 15, 2018
Phase: Phase 4
Study type: Interventional

This study evaluates if early provision of antibiotics is a superior treatment compared to "traditional wait and see" with regard to symptom relief for suspected acute uncomplicated appendicitis.

NCT ID: NCT03983031 Completed - Clinical trials for Obsessive-Compulsive Disorder

Rituximab for Obsessive-compulsive Disorder. (RITS-PO-2019)

Start date: August 8, 2019
Phase: Phase 1
Study type: Interventional

This study evaluates the addition of rituximab to 12 patients diagnosed with treatment resistant obsessive-compulsive disorder in an open trial.

NCT ID: NCT03983018 Completed - Clinical trials for Schizophrenia Spectrum and Other Psychotic Disorders

Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019)

Start date: August 7, 2019
Phase: Phase 1
Study type: Interventional

This study evaluates the addition of rituximab to 12 patients diagnosed with treatment resistant schizophrenia spectrum disorder in an open trial.